N. SOYER Et Al. , "Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis," 4th Aegean Hematology Oncology Symposium , 2017
SOYER, N. Et Al. 2017. Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis. 4th Aegean Hematology Oncology Symposium .
SOYER, N., TURGUT, M., HAZNEDAROĞLU, İ. C., YILMAZ, F., AYDOĞDU, İ., PİR, A., ... KARAKUŞ, V.(2017). Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis . 4th Aegean Hematology Oncology Symposium
SOYER, NUR Et Al. "Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis," 4th Aegean Hematology Oncology Symposium, 2017
SOYER, NUR Et Al. "Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis." 4th Aegean Hematology Oncology Symposium , 2017
SOYER, N. Et Al. (2017) . "Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis." 4th Aegean Hematology Oncology Symposium .
@conferencepaper{conferencepaper, author={NUR SOYER Et Al. }, title={Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis}, congress name={4th Aegean Hematology Oncology Symposium}, city={}, country={}, year={2017}}